IO Clinical Trials During COVID-19

Jun 23, 2020

On this episode of CANCER BUZZ, we look at how immunotherapy clinical trials have been affected by the pandemic and what cancer programs can do to safely and effectively administer clinical trials.

Guest:

• Joanne Riemer, RN, BSN, Research Oncology Nurse, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD 

Related Content:

• Immunotherapy Clinical Trials During COVID-19 (ACCCBuzz blog post)
• Clinical Trials & COVID-19: Charting New Territory (ACCCBuzz blog post)
• Clinical Trials Amid COVID-19 (webcast)
• Podcast Episode 6: Clinical Trial Access in Rural Areas
• Podcast Episode 10: The Immunotherapy Patient Perspective
• ACCC President's Theme 2020-2021: Community Oncology Can Close the Gap in Cancer Research

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.